AVIR
Price
$3.18
Change
-$0.01 (-0.31%)
Updated
Jun 6 closing price
Capitalization
273M
59 days until earnings call
GALT
Price
$1.32
Change
+$0.02 (+1.54%)
Updated
Jun 6 closing price
Capitalization
81.65M
71 days until earnings call
Interact to see
Advertisement

AVIR vs GALT

Header iconAVIR vs GALT Comparison
Open Charts AVIR vs GALTBanner chart's image
Atea Pharmaceuticals
Price$3.18
Change-$0.01 (-0.31%)
Volume$542.19K
Capitalization273M
Galectin Therapeutics
Price$1.32
Change+$0.02 (+1.54%)
Volume$242.98K
Capitalization81.65M
AVIR vs GALT Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. GALT commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Buy and GALT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (AVIR: $2.93 vs. GALT: $1.29)
Brand notoriety: AVIR and GALT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 68% vs. GALT: 65%
Market capitalization -- AVIR: $273M vs. GALT: $81.65M
AVIR [@Biotechnology] is valued at $273M. GALT’s [@Biotechnology] market capitalization is $81.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileGALT’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • GALT’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than GALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while GALT’s TA Score has 3 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 3 bearish.
  • GALT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AVIR is a better buy in the short-term than GALT.

Price Growth

AVIR (@Biotechnology) experienced а +4.45% price change this week, while GALT (@Biotechnology) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

AVIR is expected to report earnings on Aug 06, 2025.

GALT is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($273M) has a higher market cap than GALT($81.6M). GALT YTD gains are higher at: 0.000 vs. AVIR (-12.388). GALT has higher annual earnings (EBITDA): -40.38M vs. AVIR (-192.53M). AVIR has more cash in the bank: 455M vs. GALT (27.1M). AVIR has less debt than GALT: AVIR (1.64M) vs GALT (105M). AVIR (0) and GALT (0) have equivalent revenues.
AVIRGALTAVIR / GALT
Capitalization273M81.6M335%
EBITDA-192.53M-40.38M477%
Gain YTD-12.3880.000-
P/E RatioN/AN/A-
Revenue00-
Total Cash455M27.1M1,679%
Total Debt1.64M105M2%
FUNDAMENTALS RATINGS
AVIR vs GALT: Fundamental Ratings
AVIR
GALT
OUTLOOK RATING
1..100
581
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6186
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
41n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for GALT (96). This means that AVIR’s stock grew somewhat faster than GALT’s over the last 12 months.

AVIR's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as GALT (100). This means that AVIR’s stock grew similarly to GALT’s over the last 12 months.

AVIR's SMR Rating (96) in the Biotechnology industry is in the same range as GALT (100). This means that AVIR’s stock grew similarly to GALT’s over the last 12 months.

AVIR's Price Growth Rating (61) in the Biotechnology industry is in the same range as GALT (86). This means that AVIR’s stock grew similarly to GALT’s over the last 12 months.

AVIR's P/E Growth Rating (95) in the Biotechnology industry is in the same range as GALT (100). This means that AVIR’s stock grew similarly to GALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRGALT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
79%
Momentum
ODDS (%)
Bullish Trend 12 days ago
75%
Bearish Trend 12 days ago
86%
MACD
ODDS (%)
Bullish Trend 12 days ago
64%
Bearish Trend 12 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
75%
Bearish Trend 12 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 26 days ago
80%
Bearish Trend 19 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
89%
Bearish Trend 12 days ago
80%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with IMNM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-0.51%
IMNM - AVIR
46%
Loosely correlated
+0.35%
MGTX - AVIR
45%
Loosely correlated
+0.20%
FHTX - AVIR
45%
Loosely correlated
+6.17%
XENE - AVIR
44%
Loosely correlated
-3.29%
KALV - AVIR
43%
Loosely correlated
+1.60%
More

GALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, GALT has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GALT jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
-1.53%
BCAB - GALT
37%
Loosely correlated
+2.18%
NVO - GALT
33%
Poorly correlated
-2.61%
RNAC - GALT
32%
Poorly correlated
+3.65%
SNPX - GALT
32%
Poorly correlated
-10.74%
AVIR - GALT
30%
Poorly correlated
-0.51%
More